Our results may provide valuable information on TAMs and PD-L1 in the prognosis of PCa and may also guide macrophage-targeting strategies to improve the current poor efficacy of PD-1/PD-L1 blockade therapy for PCa. This evidence concerns the gene CD274 and posterior cortical atrophy.